Your Messages Inbox
Your Article Summary
See Latest ArticlesBiopure Receives Extension of Time to Regain NASDAQ Listing Compliance
BioPure, 08/04/09
Biopure Corporation announced that it has received notice from The NASDAQ Stock Market stating that NASDAQ has again suspended enforcement of its minimum bid price and market value requirements for continued listing, thereby extending the Company's time in which to gain compliance. Enforcement of these rules is scheduled to resume on Monday, April 2009.
Today in Regulatory Issues...keeping you current
Receive free subspecialty "5-minute updates" via email
FDA drug approval intervals from 1997 to 2006: analysis and comparison during information technology implementation
International Journal of Electronic Healthcare , 12/01/09
Regulatory Update: GSK files Rotarix for prevention of rotavirus in Japan
GlaxoSmithKline, 12/01/09
Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease
Shire, 11/30/09
Article Search
Sponsor